A review of 25 randomized clinical trials (RCTs) on vitamin D supplementation for COVID-19 highlights inconsistent evidence on its preventive or clinical outcome benefits. The review emphasizes serum 25-hydroxyvitamin D concentration as a key indicator of supplementation effect but notes its unreliability in predicting COVID-19 outcomes.